Pharmazell is a leading independent manufacturer of APIs for the growing generics market, focusing on niche, specialty and evergreen APIs that require complex or innovative manufacturing processes. Pharmazell enjoys leading market positions in steroids, 5-ASA, amino acids and propafenone, complemented by an attractive development pipeline in anti-cancer and high potency substances. Primary markets are highly regulated and customers include a blue-chip list of major generics and pharmaceutical companies. Pharmazell runs fully FDA and GMP approved production facilities in Germany, Italy, Switzerland and India.